---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-030623"
form_type: "8-K"
ticker: "OCGN"
cik: "0001372299"
company_name: "Ocugen, Inc."
filed_at: "2022-03-04T23:59:59+00:00"
generated_at: "2026-06-27T01:28:56.990575+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Ocugen: FDA declines to issue EUA for COVAXIN in pediatric population (ages 2-18)

## Summary
- CFO Sanjay Subramanian resigns effective March 18, 2022; no disagreement with company.
- Board appoints Jessica Crespo (VP Corporate Controller) as Chief Accounting Officer and SVP Finance.
- FDA declined to issue Emergency Use Authorization for COVAXIN for ages 2-18.
- Ocugen intends to continue working with FDA to evaluate regulatory pathway for pediatric use.

## SEC filing metadata
- accession: 0001104659-22-030623
- form_type: 8-K
- ticker: OCGN
- cik: 0001372299
- company_name: Ocugen, Inc.
- filed_at: 2022-03-04T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1372299/000110465922030623/0001104659-22-030623-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1372299/000110465922030623/tm228454d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-030623
- JSON: https://secwatch.observer/filing/0001104659-22-030623.json
- Plain text: https://secwatch.observer/filing/0001104659-22-030623.txt

## Key facts
- Executive change
  Sanjay S. Subramanian resigned as Chief Financial Officer at Ocugen, Inc..
  - Action: resigned
  - Role: Chief Financial Officer
  source text: On March 2, 2022, Sanjay S. Subramanian, Chief Financial Officer and Head of Corporate Development of Ocugen, Inc. (the “Company”), tendered his resignation to the Company, effective as of March 18, 2022 (the “Effective Date”), in order to pursue new opportunities.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1372299/000110465922030623/0001104659-22-030623-index.htm
- Executive change
  Jessica Crespo was appointed as Chief Accounting Officer and Senior Vice President, Finance at Ocugen, Inc..
  - Action: appointed
  - Role: Chief Accounting Officer and Senior Vice President, Finance
  source text: On March 4, 2022, the Board appointed Jessica Crespo, the Company’s Vice President, Corporate Controller & Treasurer, to Chief Accounting Officer and Senior Vice President, Finance, effective as of the Effective Date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1372299/000110465922030623/0001104659-22-030623-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.